04:28 AM EDT, 09/02/2026 (MT Newswires) -- Novonesis (NSIS-B.CO) said Wednesday it will expand its site in Patalganga, India, to establish a new enzyme production facility. The Danish biosolutions company will invest 600 million euros to build the facility, which will increase its capacity to produce enzymes for a range of industries, including biofuels, household care, and food and beverages. The facility is expected to be fully operational by 2030.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.